Pharma: Other News To Note

 Taro Pharmaceutical Industries Ltd., of Yakum, Israel, and Sun Pharmaceutical Industries Ltd., of Mumbai, India, agreed to terminate their merger agreement of August 2012, which would have given shareholders of Taro $39.50 per share upon closing.